The group's principal activity is to design and develop proprietary technologies to provide information that could be used to understand genetic variation and function in the united states. the group's proprietary beadarray technology enables the large-scale analysis of genetic variation and function which would help extract medically valuable information from raw genetic data. the tools provide information that could be used by life sciences and pharmaceutical companies to improve drugs and therapies, customize diagnoses and treatment and cure diseases. in addition, the group's complementary oligator technology permits parallel synthesis of the millions of different pieces of dna necessary to perform large-scale genetic analysis on arrays. the group's technology has applicability across a wide variety of industries, including agriculture, petrochemicals and food, flavor and beverages.